Cargando…
Risk factors of malignant fluorodeoxyglucose-avid lymph node on preablation positron emission tomography in patients with papillary thyroid cancer undergoing radioiodine ablation therapy
F-18 fluorodeoxyglucose (FDG)-avid metastatic lesions are associated with a poor response to radioiodine ablation therapy (RIT) in papillary thyroid cancer (PTC). This study evaluated the significance of preablative FDG positron emission tomography (PET) for the assessment of risk factors and freque...
Autores principales: | Cho, Sang-Geon, Kwon, Seong Young, Kim, Jahae, Cho, Dong-Hyeok, Na, Myung Hwan, Kang, Sae-Ryung, Yoo, Su Woong, Song, Ho-Chun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6494284/ https://www.ncbi.nlm.nih.gov/pubmed/31008921 http://dx.doi.org/10.1097/MD.0000000000014858 |
Ejemplares similares
-
Preparation for radioactive iodine therapy is not a risk factor for the development of hyponatremia in thyroid cancer patients
por: Kim, Jahae, et al.
Publicado: (2017) -
Both F-18 FDG-avidity and Malignant Shape of Cervical Lymph Nodes on PET/CT after Total Thyroidectomy Predict Resistance to High-dose I-131 Therapy in Patients with Papillary Thyroid Cancer
por: Byun, Byung Hyun, et al.
Publicado: (2013) -
The clinical meaning of pre- and post-ablation thyroglobulin levels at first radioiodine therapy in patients with papillary thyroid cancer
por: Kim, Hee Kyung, et al.
Publicado: (2020) -
Unusual Asymptomatic Fluorodeoxyglucose Avid Pheochromocytoma in a Case of Myxoid Liposarcoma of the Extremity on (18)-F Fluorodeoxyglucose Positron Emission Tomography-computed Tomography
por: Shivdasani, Divya, et al.
Publicado: (2017) -
Do radioiodine-avid lymph nodes from differentiated thyroid cancer on the initial posttherapy scan need repeated (131)I therapy?
por: Jiang, Yongji, et al.
Publicado: (2023)